Thursday, 31 October 2019

European agency highlights blood clot risks from Pfizer's arthritis drug

Pfizer Inc's rheumatoid arthritis drug Xeljanz could increase the risk of blood clots in the lungs and in deep veins, the European Medicines Agency (EMA) said on Thursday.


Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)